Posted by Michael Wonder on 17 Oct 2025
Immunotherapy for patients with advanced cancers
17 October 2025 - More Australians living with advanced cancer could have access to immunotherapy treatment options, thanks to a new recommendation from the independent PBAC.
The PBAC has backed listing nivolumab (Opdivo) and ipilimumab (Yervoy) on the PBS for a wider range of advanced and metastatic cancers.
